U.S. Markets open in 2 hrs 55 mins
  • S&P Futures

    4,169.50
    -6.75 (-0.16%)
     
  • Dow Futures

    34,012.00
    -69.00 (-0.20%)
     
  • Nasdaq Futures

    14,015.75
    -13.75 (-0.10%)
     
  • Russell 2000 Futures

    2,245.10
    -13.90 (-0.62%)
     
  • Crude Oil

    63.10
    -0.03 (-0.05%)
     
  • Gold

    1,789.60
    +9.40 (+0.53%)
     
  • Silver

    26.25
    +0.14 (+0.54%)
     
  • EUR/USD

    1.2041
    +0.0061 (+0.5057%)
     
  • 10-Yr Bond

    1.5730
    0.0000 (0.00%)
     
  • Vix

    17.07
    +0.50 (+3.02%)
     
  • GBP/USD

    1.3900
    +0.0060 (+0.4323%)
     
  • USD/JPY

    108.1350
    -0.6480 (-0.5957%)
     
  • BTC-USD

    56,472.16
    +1,800.21 (+3.29%)
     
  • CMC Crypto 200

    1,281.61
    -110.10 (-7.91%)
     
  • FTSE 100

    7,035.68
    +16.15 (+0.23%)
     
  • Nikkei 225

    29,685.37
    +2.00 (+0.01%)
     

Agilent Technologies: Q4 Earnings Insights

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Agilent Technologies (NYSE:A) fell 2.53% in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share rose 10.11% over the past year to $0.98, which beat the estimate of $0.93.

Revenue of $1,483,000,000 higher by 8.49% from the same period last year, which beat the estimate of $1,400,000,000.

Guidance

Agilent Sees Q1 Adj. EPS $0.85-$0.88 vs $0.88 Est., Sales $1.42B-$1.43B vs $1.4B Est.; Sees FY21 Adj. EPS $3.57-$3.67 vs $3.68 Est., Sales $5.6B-$5.7B vs $5.67B Est.

Details Of The Call

Date: Nov 23, 2020

Time: 04:30 PM

View more earnings on A

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.investor.agilent.com%2F&eventid=2626386&sessionid=1&key=606DDF936B1155263C494F86F6F156DF&regTag=&sourcepage=register

Recent Stock Performance

52-week high: $117.50

52-week low: $61.13

Price action over last quarter: Up 10.88%

Company Description

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2019 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (31%) and China (20%) representing the largest country concentrations.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.